Klug-entscheiden-Empfehlungen in der Kardiologie

• Verfasst von: Werdan, Karl [VerfasserIn]
• Verfasst von: Katus, Hugo [VerfasserIn]
• Titel: Klug-entscheiden-Empfehlungen in der Kardiologie
• Verf.angabe: K. Werdan, S. Baldus, N. Frey, U. Nixdorff, K.-H. Kuck, H. Katus
• E-Jahr: 2017
• Jahr: June 2017
• Umfang: 12 S.
• Fussnoten: Gesehen am 26.11.2018
• Titel Quelle: Enthalten in: Der Internist
• Ort Quelle: Berlin : Springer, 1996
• Jahr Quelle: 2017
• Band/Heft Quelle: 58(2017), 6, Seite 556-567
• ISSN Quelle: 1432-1289
• DOI: doi:10.1007/s00108-017-0239-7
• Datenträger: Online-Ressource
• Sprache: ger
• Sach-SW: Anticoagulants
• Sach-SW: Antikoagulanzien
• Sach-SW: Atrial fibrillation
• Sach-SW: Cholesterol
• Sach-SW: Coronary disease
• Sach-SW: Hydroxymethylglutaryl-CoA reductase inhibitors
• Sach-SW: Hydroxymethylglutaryl-CoA-Reduktase-Hemmer
• Sach-SW: Koronare Herzkrankheit
• Sach-SW: LDL
• Sach-SW: LDL-Cholesterin
• Sach-SW: Vorhofflimmern
• K10plus-PPN: 158442933X

Abstract

This article describes controversially discussed Choosing wisely recommendations presented by the German Cardiac Society: anticoagulation therapy in patients with atrial fibrillation and “only” moderate stroke risk, on the one hand, and goal-directed low-density lipoprotein (LDL) cholesterol-lowering, on the other. Presuming an adequate regime, patients with atrial fibrillation and only moderate risk of stroke (CHA2DS2-VASc Score of 1 in men and of 2 in women) also benefit from anticoagulation therapy, even in elderly patients. In patients with coronary heart disease, the German Cardiac Society recommends reducing LDL-cholesterol serum levels with a statin to values lower than 70 mg/dl (1.8 mmol/l) or at least reducing the basal level by 50%. With this recommendation, the German Cardiac Society unequivocally prioritizes the “goal-oriented statin therapy” above the “statin strategy of fixed dose”. The reasons for this preference are discussed.